Preview: Paxmedica, Inc. Set To IPO Tomorrow


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


PAXMEDICA, INC. (NASDAQ:PXMD) IPO will take place August, 24 on the NASDAQ exchange under the ticker PXMD.

The company is offering shares at an expected price between $4.50 and $6.50 per share with an insider lock-up period of 180 days ending on February 20, 2023.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

See also: Benzinga IPO Calendar

About PAXMEDICA, INC.

PAXMEDICA, INC is a clinical stage biopharmaceutical company focusing on the development of APT for the treatment of disorders with intractable neurologic symptoms

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: IPOsBZI-IPOPreview